tiprankstipranks
Zelira Therapeutics (ZLDAF)
OTHER OTC:ZLDAF

Zelira Therapeutics (ZLDAF) Technical Analysis

16 Followers

Summary of all the Indicators

Overall Consensus
Sell
4Bullish
6Neutral
12Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Zelira Therapeutics’s (ZLDAF) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Zelira Therapeutics is a Sell.
Zelira Therapeutics’s (ZLDAF) 20-Day exponential moving average is 0.49, while Zelira Therapeutics’s (ZLDAF) share price is $0.531, making it a Sell.
Zelira Therapeutics’s (ZLDAF) 50-Day exponential moving average is 0.53, while Zelira Therapeutics’s (ZLDAF) share price is $0.531, making it a Sell.

Zelira Therapeutics (ZLDAF) Pivot Points

Apr 28, 2024, 08:41 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.36
0.40
0.43
0.47
0.51
0.55
0.59
Fibonacci
0.40
0.43
0.44
0.47
0.50
0.52
0.55
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Zelira Therapeutics (ZLDAF) Moving Averages

Apr 28, 2024, 08:41 PM
Period
Simple
Exponential
MA5
0.47Buy
0.47Buy
MA10
0.47Buy
0.47Sell
MA20
0.49Sell
0.49Sell
MA50
0.54Sell
0.53Sell
MA100
0.58Sell
0.58Sell
MA200
0.71Sell
0.67Sell
Zelira Therapeutics’s (ZLDAF) 10-Day exponential moving average is 0.47, while Zelira Therapeutics’s (ZLDAF) share price is $0.531, making it a Sell.
Zelira Therapeutics’s (ZLDAF) 100-Day exponential moving average is 0.58, while Zelira Therapeutics’s (ZLDAF) share price is $0.531, making it a Sell.
Zelira Therapeutics’s (ZLDAF) stock price is $0.531 and Zelira Therapeutics’s (ZLDAF) 50-day simple moving average is 0.54, creating a Sell signal.
Zelira Therapeutics’s (ZLDAF) stock price is $0.531 and Zelira Therapeutics’s (ZLDAF) 100-day simple moving average is 0.58, creating a Sell signal.
Zelira Therapeutics’s (ZLDAF) stock price is $0.531 and Zelira Therapeutics’s (ZLDAF) 200-day simple moving average is 0.71, creating a Sell signal.

Zelira Therapeutics (ZLDAF) Technical Indicators

Apr 28, 2024, 08:41 PM
Name
Value
Implied Action
RSI (14)
37.31
Neutral
STOCH (9,6)
52.95
Neutral
STOCHRSI (14)
41.18
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
25.69
Neutral
Williams %R
-58.82
Buy
CCI (14)
-50.23
Neutral
ATR (14)
0.07
-
Ultimate Oscillator
49.85
Neutral
ROC
-2.08
Sell
Zelira Therapeutics’s (ZLDAF) Relative Strength Index (RSI) is 37.31, creating a Neutral signal.
Zelira Therapeutics’s (ZLDAF) Trend Strength Indicator (ADX) is 25.69, creating a Neutral signal.
Zelira Therapeutics’s (ZLDAF) Commodity Channel Index (CCI) is -50.23, creating a Neutral signal.
Zelira Therapeutics’s (ZLDAF) Price Rate of Change (ROC) is -2.08, creating a Sell signal.

FAQ

Is ZLDAF a Buy, Hold, or Sell?
Based on ZLDAF’s technical indicators, ZLDAF is a Sell.
    What is ZLDAF’s RSI (14)?
    ZLDAF’s RSI (14) is 37.31, which suggests ZLDAF is a Neutral.
      What is ZLDAF’s MACD?
      ZLDAF’s MACD is -0.02, which suggests ZLDAF is a Sell.
        What is ZLDAF’s 5-day moving average?
        ZLDAF’s 5-day moving average is 0.47, which suggests ZLDAF is a Buy.
          What is ZLDAF’s 20-day moving average?
          ZLDAF 20-day moving average is 0.49, which suggests ZLDAF is a Sell.
            What is ZLDAF’s 50-day moving average?
            ZLDAF’s 50-day moving average is 0.54, which suggests ZLDAF is a Sell.
              What is ZLDAF’s 200-day moving average?
              ZLDAF’s 200-day moving average is 0.71, which suggests ZLDAF is a Sell.
                What is ZLDAF’s Williams % R (14)?
                ZLDAF’s Williams % R (14) is -58.82, which suggests ZLDAF is a Buy.
                  What is ZLDAF’s CCI (14)?
                  ZLDAF’s CCI (14) is -50.23, which suggests ZLDAF is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis